CAMP4 Therapeutics
company
About
CAMP4 Therapeutics is a biotechnology company that uses RNA to restore healthy gene expression.
- 1 - 10
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- $100M
- Industries
- Biopharma,Biotechnology,Therapeutics
- Founded date
- Jan 1, 2016
- Number Of Employee
- 1 - 10
- Operating Status
- Active
CAMP4 is focused on addressing the fundamental cause of disease by controlling the output of genes central to disease. By taking advantage of the gene circuitry code, CAMP4 is able to control gene production through signaling pathways the cell is already utilizing to regulate gene expression. Their predictions enables CAMP4 to have a rapid start to disease treatment, significantly reducing the time and risk to bring new medicines to patients.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$100M
CAMP4 Therapeutics has raised a total of
$100M
in funding over 2 rounds. Their latest funding was raised on
Jul 20, 2022 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jul 20, 2022 | Series B | $100M | 1 | — | — | Detail |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
